UNIMAS News

  • Submit Your Article

  • Archived News

    • Events Calendar

    Download as iCal file
    Visit and MOU Signing Ceremony between UNIMAS and RCert Sdn Bhd
    Friday 03 May 2024
    Hits : 683
     
    by This email address is being protected from spambots. You need JavaScript enabled to view it.
    IMG_6278.jpg
    On May 2, 2024, the Faculty of Medicine and Health Sciences warmly welcomed a delegation from RCERT Sdn Bhd, a Biotechnology company and Zhongrong Medical Group, a medical company based in Qingdoa China, led by the esteemed Datuk Seri Dr. Chen Chaw Min, Chairman of RCERT Sdn Bhd. The visit was marked with anticipation as both parties aimed to explore potential collaborations in stem cell research.
    The objective of the visit was  to provide the RCERT delegates with an understanding of the facilities available at the Faculty of Medicine and Health Sciences, and to engage in discussions regarding the collaborations between the Therapeutics Research Centre of the Faculty and RCERT Sdn Bhd.
     
    IMG 6316
    IMG 6287
    IMG 6360
    The visit served as a  future partnerships that have the potential to drive innovation and make significant advancements in the field of stem cell technologies.

    Following the visit, the collaboration between UNIMAS and RCERT Sdn Bhd was solidified with the signing of a Memorandum of Understanding (MOU). This momentous occasion formalized the strategic partnership between the Therapeutics Research Centre of the Faculty of Medicine and Health Sciences at UNIMAS and RCERT Sdn Bhd in stem cell technologies. The momentous occasion was witnessed by Yang Berhormat Datuk Amar Profesor Dr Sim Kui Hian, Deputy Premier of Sarawak and Minister of Public Health, Housing and Local Government of Sarawak.

    The MOU outlines a comprehensive framework for cooperation, focusing on the transfer of advanced stem cell technologies, expertise, and knowledge. Specifically, the collaboration will delve into various areas of cellular therapy, including chimeric antigen receptor (CAR) T Cell therapy, a cutting-edge approach in cancer treatment.

    Under the terms of the MOU, both parties commit to joint training programs, facilitating the exchange of researchers, and collaborative research initiatives. Moreover, the establishment of a dedicated cell laboratory within Faculty of Medicine and Health Sciences, UNIMAS will serve as a focal point for innovation and research in stem cell technologies.

    Thank you to Prof Dr Ahmad Hata bin Rasit, Vice Chancellor UNIMAS and Prof Dr Lo May Chiun, Senior Director Center for Research, Innovation and Enterprise for their support and making this collaboration possible.

    DSC 9691

    DSC 9694

     
    Attachment(s):
     
     
    Demo